Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension
An initial oral combination of drugs is being recommended in pulmonary arterial hypertension (PAH), but the effects of this approach on risk reduction and pulmonary vascular resistance (PVR) are not known.